Alamar Biosciences
Powering Precision Proteomics
- Headquarters
- Fremont
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- alamarbio.com
- Total Funding
- $258.0M
- Last Round
- $50.0M Convertible NoteJan 2026
About
Alamar Biosciences, Inc. is a life science tools company founded in 2018 and headquartered in Fremont, California. The company develops and commercializes the NULISA platform — a next-generation proteomics technology enabling ultra-high sensitivity protein quantification at scale. Alamar's solutions are used in biomarker discovery, early disease detection (including cancer and neurodegenerative diseases), and pharmaceutical research. The company has raised over $170M and serves academic research centers and biopharma customers globally.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account